Abstract
Neonatal hypoxic-ischemic (HI) brain injury is a leading cause of long-term neurological impairment in newborns. While current treatments are limited, intranasal mesenchymal stem cell (MSC) therapy has shown safety in humans and the potential to repair HI brain injury in preclinical studies. Although its potential, MSC therapy remains only partially
... read more